Tag Archives: Imlygic

Cancer immunotherapy, research funding, and new cancer drugs – a year in review

It has been a while since I submitted a blog entry, and one of my New Year’s resolutions is that I will get back to posting entries more regularly. I thought I would start with a summary of the past year in the field of cancer in general and the Holden Comprehensive Cancer Center in particular.
Continue reading